SecBot SecBot
SECBOTREPLAY Home › Report › INO

INO · Inovio Pharmaceuticals priced a $20M public offering of 21M shares and…

INOVIO PHARMACEUTICALS, INC. · 8-K filed Jul 31, 2026 at 07:23 ET

At the news

BEARISHIMPACT 6/10

8-K filed Jul 31, 2026 at 07:23 ET

Inovio Pharmaceuticals priced a $20M public offering of 21M shares and warrants for 42M shares (or pre-funded warrants) at $0.95/unit, with net proceeds of ~$18.3M. The underwriter exercised an option for additional warrants covering 6.3M shares. This dilutive capital raise follows a prior going-concern disclosure and adds ~30% immediate dilution plus significant warrant overhang, reinforcing the bearish outlook.

  • Offering of 21,052,632 shares and warrants to purchase up to 42,105,264 shares at $0.95/unit
  • Underwriter exercised option for warrants to purchase an additional 6,315,788 shares
  • Net proceeds expected to be approximately $18.3 million
  • Warrants have a $1.10 exercise price, 5-year term, with beneficial ownership limitations

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access